Masculinizing hormone therapy - Revision history

Ondo at 16:22, 24 December 2024

2024-12-24T16:22:41Z

← Older revision		Revision as of 16:22, 24 December 2024
Line 1:		Line 1:
	{{content warning\|private body parts and periods}}		{{content warning\|private body parts and periods}}
	{{disclaimer\|~~The Nonbinary Wiki is written by volunteers who are not necessarily experts on~~ medical topics. This wiki and its editors make no representations or warranties of any kind. This wiki and its editors shall not be liable for any physical, psychological, emotional, financial, or commercial damages, prosecutions, or proceedings instituted against any person or entity as a result of the use of information from this file, or any loss, injury, or damage caused thereby. You claim full responsibility for your own health decisions. This wiki will not be held responsible for your actions. Any information here does not constitute legal, financial, medical, business, or other advice. This wiki should not be used to recommend a path for diagnosing or treating any medical condition. For that, you must consult your physician.}}		{{disclaimer\|medical}}

	[[Masculinizing hormone therapy]], also called masculinizing hormone replacement therapy, androgen hormone therapy, transgender hormone therapy of the masculinizing type, transmasculine hormone therapy, or female-to-male (FTM) hormone therapy, is a form of [[hormone therapy]] or hormone replacement therapy (HRT). Masculinizing hormone therapy means taking certain kinds of medicine to make a person physically look, sound, and even smell masculine, so that one is generally seen as a [[man]] by most people.		[[Masculinizing hormone therapy]], also called masculinizing hormone replacement therapy, androgen hormone therapy, transgender hormone therapy of the masculinizing type, transmasculine hormone therapy, or female-to-male (FTM) hormone therapy, is a form of [[hormone therapy]] or hormone replacement therapy (HRT). Masculinizing hormone therapy means taking certain kinds of medicine to make a person physically look, sound, and even smell masculine, so that one is generally seen as a [[man]] by most people.

InternetArchiveBot: Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5

2024-01-26T01:50:22Z

Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5

← Older revision		Revision as of 01:50, 26 January 2024
Line 348:		Line 348:
	*[https://web.archive.org/web/20120418075721/http://www.forge-forward.org/socialsupport/hormones2003.html FTM Hormone Information] - Very informative with different topics than this article		*[https://web.archive.org/web/20120418075721/http://www.forge-forward.org/socialsupport/hormones2003.html FTM Hormone Information] - Very informative with different topics than this article
	*[https://web.archive.org/web/20070315211232/http://www.dph.sf.ca.us/chn/HlthCtrs/HlthCtrDocs/TransGendprotocols.pdf Tom Waddell Clinic Transgender Protocol] - MTF and FTM clinical protocols aimed at providers		*[https://web.archive.org/web/20070315211232/http://www.dph.sf.ca.us/chn/HlthCtrs/HlthCtrDocs/TransGendprotocols.pdf Tom Waddell Clinic Transgender Protocol] - MTF and FTM clinical protocols aimed at providers
	*[~~http~~://www.nickgorton.org Medical Therapy and Health Maintenance for Transgender Men: A Guide For Health Care Providers]: a free online medical book.		*[https://web.archive.org/web/20210501005033/https://www.nickgorton.org/ Medical Therapy and Health Maintenance for Transgender Men: A Guide For Health Care Providers]: a free online medical book.

	[[Category:Transition]]		[[Category:Transition]]

InternetArchiveBot: Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5

2023-12-11T01:32:54Z

Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5

← Older revision		Revision as of 01:32, 11 December 2023
Line 340:		Line 340:
	{{reflist}}		{{reflist}}
	*[http://www3.interscience.wiley.com/journal/119425589/abstract Androgen Treatment of Female-to-Male]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Louis J.G. Gooren, and Erik J. Giltay (Journal of Sexual Medicine, Volume 5 Issue 4, Oct 2007)		*[http://www3.interscience.wiley.com/journal/119425589/abstract Androgen Treatment of Female-to-Male]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Louis J.G. Gooren, and Erik J. Giltay (Journal of Sexual Medicine, Volume 5 Issue 4, Oct 2007)
	*[http://www.eje-online.org/cgi/content/abstract/159/3/197 Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones] by Andreas Mueller and Louis Gooren (European Journal of Endocrinology, Vol 159, Issue 3, 197-202)		*[https://web.archive.org/web/20100722071041/http://www.eje-online.org/cgi/content/abstract/159/3/197 Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones] by Andreas Mueller and Louis Gooren (European Journal of Endocrinology, Vol 159, Issue 3, 197-202)
	*[http://www3.interscience.wiley.com/journal/122667383/abstract Testosterone and Breast Cancer]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Susan A. Hall, Andre B. Araujo, Varant Kupelian, Nancy N. Maserejian, and Thomas G. Travison (Journal of Sexual Medicine, Not yet in print)		*[http://www3.interscience.wiley.com/journal/122667383/abstract Testosterone and Breast Cancer]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Susan A. Hall, Andre B. Araujo, Varant Kupelian, Nancy N. Maserejian, and Thomas G. Travison (Journal of Sexual Medicine, Not yet in print)
	*[http://www3.interscience.wiley.com/journal/122463029/abstract Absorption of Testosterone Gel 1% (Testim) from Three Different Application Sites]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Andre T. Guay, Ted M. Smith, and Laura A. Offutt (Journal of Sexual Medicine, Volume 6 Issue 9, Jun 2009)		*[http://www3.interscience.wiley.com/journal/122463029/abstract Absorption of Testosterone Gel 1% (Testim) from Three Different Application Sites]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Andre T. Guay, Ted M. Smith, and Laura A. Offutt (Journal of Sexual Medicine, Volume 6 Issue 9, Jun 2009)

InternetArchiveBot: Rescuing 3 sources and tagging 0 as dead.) #IABot (v2.0.9.5

2023-07-28T01:45:51Z

Rescuing 3 sources and tagging 0 as dead.) #IABot (v2.0.9.5

← Older revision		Revision as of 01:45, 28 July 2023
Line 125:		Line 125:
	A 2006 study found that HRT in trans men correlates with in an increase in brain volume up to male proportions.<ref name="eje-utrecht">{{cite journal\|author=Hulshoff, Cohen-Kettenis\|date=July 2006\|title=Changing your sex changes your brain: influences of testosterone and estrogen on adult human brain structure\|url=http://www.eje-online.org/cgi/content/abstract/155/suppl_1/S107\|journal=European Journal of Endocrinology\|issue=suppl_1\|pages=107–114\|doi=10.1530/eje.1.02248\|issn=0804-4643\|volume=155\|display-authors=1\|last2=Cohen-Kettenis\|first2=P. T\|last3=Van Haren\|first3=N. E M\|last4=Peper\|first4=J. S\|last5=Brans\|first5=R. G H\|last6=Cahn\|first6=W.\|last7=Schnack\|first7=H. G\|last8=Gooren\|first8=L. J G\|last9=Kahn\|first9=R. S\|access-date=2007-12-12\|archive-url=https://web.archive.org/web/20110411003628/http://www.eje-online.org/cgi/content/abstract/155/suppl_1/S107\|archive-date=2011-04-11\|url-status=dead\|doi-access=free}}</ref>		A 2006 study found that HRT in trans men correlates with in an increase in brain volume up to male proportions.<ref name="eje-utrecht">{{cite journal\|author=Hulshoff, Cohen-Kettenis\|date=July 2006\|title=Changing your sex changes your brain: influences of testosterone and estrogen on adult human brain structure\|url=http://www.eje-online.org/cgi/content/abstract/155/suppl_1/S107\|journal=European Journal of Endocrinology\|issue=suppl_1\|pages=107–114\|doi=10.1530/eje.1.02248\|issn=0804-4643\|volume=155\|display-authors=1\|last2=Cohen-Kettenis\|first2=P. T\|last3=Van Haren\|first3=N. E M\|last4=Peper\|first4=J. S\|last5=Brans\|first5=R. G H\|last6=Cahn\|first6=W.\|last7=Schnack\|first7=H. G\|last8=Gooren\|first8=L. J G\|last9=Kahn\|first9=R. S\|access-date=2007-12-12\|archive-url=https://web.archive.org/web/20110411003628/http://www.eje-online.org/cgi/content/abstract/155/suppl_1/S107\|archive-date=2011-04-11\|url-status=dead\|doi-access=free}}</ref>

	On the other hand, the reality of distinct differences between the brains of men and women is disputed by various neurologists. British neuroscientist Gina Rippon, author of the 2019 book ''Gendered Brain: The New Neuroscience that Shatters the Myth of the Female Brain'', argues that there is not a "single item type as a male brain or a female brain", instead that "everybody is actually made up of a whole pattern of things, which is maybe due to their biology and maybe due to their different experiences in life."<ref name=":2">{{Cite news\|title='Every brain is different from every other brain’: Author Gina Rippon challenges gender stereotypes\|url=https://www.theglobeandmail.com/life/health-and-fitness/article-every-brain-is-different-from-every-other-brain-author-gina-rippon/\|access-date=2020-08-06\|archive-url=https://web.archive.org/web/20201111205327/https://www.theglobeandmail.com/life/health-and-fitness/article-every-brain-is-different-from-every-other-brain-author-gina-rippon/\|archive-date=17 July 2023}}</ref> She puts forward the idea that "every brain is different from every other brain".<ref name=":2" /> Rippon is opposed to the "continued emphasis on '[[gender essentialism\|essentialist]]', brain-based explanations in both public communication of, and research into, many forms of gender imbalance."<ref>{{cite journal \| last = Rippon \| first = Gina \| title = The trouble with girls? \| journal = [[The Psychologist (magazine)\|The Psychologist]] \| volume = 29 \| issue = 12 \| pages = 918–922 \| publisher = British Psychological Society \| date = December 2016 \| url = https://thepsychologist.bps.org.uk/volume-29/december-2016/trouble-girls \| ref = harv }}</ref>		On the other hand, the reality of distinct differences between the brains of men and women is disputed by various neurologists. British neuroscientist Gina Rippon, author of the 2019 book ''Gendered Brain: The New Neuroscience that Shatters the Myth of the Female Brain'', argues that there is not a "single item type as a male brain or a female brain", instead that "everybody is actually made up of a whole pattern of things, which is maybe due to their biology and maybe due to their different experiences in life."<ref name=":2">{{Cite news\|title='Every brain is different from every other brain’: Author Gina Rippon challenges gender stereotypes\|url=https://www.theglobeandmail.com/life/health-and-fitness/article-every-brain-is-different-from-every-other-brain-author-gina-rippon/\|access-date=2020-08-06\|archive-url=https://web.archive.org/web/20201111205327/https://www.theglobeandmail.com/life/health-and-fitness/article-every-brain-is-different-from-every-other-brain-author-gina-rippon/\|archive-date=17 July 2023}}</ref> She puts forward the idea that "every brain is different from every other brain".<ref name=":2" /> Rippon is opposed to the "continued emphasis on '[[gender essentialism\|essentialist]]', brain-based explanations in both public communication of, and research into, many forms of gender imbalance."<ref>{{cite journal \| last = Rippon \| first = Gina \| title = The trouble with girls? \| journal = [[The Psychologist (magazine)\|The Psychologist]] \| volume = 29 \| issue = 12 \| pages = 918–922 \| publisher = British Psychological Society \| date = December 2016 \| url = https://thepsychologist.bps.org.uk/volume-29/december-2016/trouble-girls \| ref = harv \| access-date = 2020-10-05 \| archive-date = 2020-11-11 \| archive-url = https://web.archive.org/web/20201111172602/https://thepsychologist.bps.org.uk/volume-29/december-2016/trouble-girls \| url-status = dead }}</ref>

	====Effects on migraines====		====Effects on migraines====
Line 223:		Line 223:

	====Implants====		====Implants====
	Implants, as subcutaneous pellets, can be used to deliver testosterone (brand name Testopel). 6 to 12 pellets are inserted under the skin every three months. This must be done in a physician's office, but is a relatively minor procedure done under local anesthetic. Pellets cost about $60 each, so the cost is greater than injected testosterone when the cost of the physician visit and procedure are included. The primary advantages of Testopel are that it gives a much more constant blood level of testosterone yet requires attention only four times yearly. One common risk of any kind of implants is that the body can reject them. This often happens with testosterone implants, causing the implant to emerge from deep and painful skin lesions. One trans-masculine blogger, K-CON, posted weekly blog updates about being on Testopel for over a year, and his resulting complications (pellets failing to dissolve at the rate claimed by the manufacturer, implant rejection, leading to infection, pain, and surgery under general anesthesia to remove the pellets and the damaged tissue). He summarized his experience in [https://k-con.today/post/172598026877/whats-testopel a post where he explains why he would not recommend Testopel to anyone].<ref>K-CON. "What's Testopel?" ''K-CON'' (personal blog). 2018. https://k-con.today/post/172598026877/whats-testopel [https://web.archive.org/web/20210206180405/https://k-con.today/post/172598026877/whats-testopel Archived] on 17 July 2023</ref>		Implants, as subcutaneous pellets, can be used to deliver testosterone (brand name Testopel). 6 to 12 pellets are inserted under the skin every three months. This must be done in a physician's office, but is a relatively minor procedure done under local anesthetic. Pellets cost about $60 each, so the cost is greater than injected testosterone when the cost of the physician visit and procedure are included. The primary advantages of Testopel are that it gives a much more constant blood level of testosterone yet requires attention only four times yearly. One common risk of any kind of implants is that the body can reject them. This often happens with testosterone implants, causing the implant to emerge from deep and painful skin lesions. One trans-masculine blogger, K-CON, posted weekly blog updates about being on Testopel for over a year, and his resulting complications (pellets failing to dissolve at the rate claimed by the manufacturer, implant rejection, leading to infection, pain, and surgery under general anesthesia to remove the pellets and the damaged tissue). He summarized his experience in [https://web.archive.org/web/20210206180405/https://k-con.today/post/172598026877/whats-testopel a post where he explains why he would not recommend Testopel to anyone].<ref>K-CON. "What's Testopel?" ''K-CON'' (personal blog). 2018. https://k-con.today/post/172598026877/whats-testopel [https://web.archive.org/web/20210206180405/https://k-con.today/post/172598026877/whats-testopel Archived] on 17 July 2023</ref>

	====Oral====		====Oral====
Line 346:		Line 346:
	==External links==		==External links==
	*[http://www.ftminfo.net/ FTM Informational Network]		*[http://www.ftminfo.net/ FTM Informational Network]
	*[http://www.forge-forward.org/socialsupport/hormones2003.html FTM Hormone Information] - Very informative with different topics than this article		*[https://web.archive.org/web/20120418075721/http://www.forge-forward.org/socialsupport/hormones2003.html FTM Hormone Information] - Very informative with different topics than this article
	*[https://web.archive.org/web/20070315211232/http://www.dph.sf.ca.us/chn/HlthCtrs/HlthCtrDocs/TransGendprotocols.pdf Tom Waddell Clinic Transgender Protocol] - MTF and FTM clinical protocols aimed at providers		*[https://web.archive.org/web/20070315211232/http://www.dph.sf.ca.us/chn/HlthCtrs/HlthCtrDocs/TransGendprotocols.pdf Tom Waddell Clinic Transgender Protocol] - MTF and FTM clinical protocols aimed at providers
	*[http://www.nickgorton.org Medical Therapy and Health Maintenance for Transgender Men: A Guide For Health Care Providers]: a free online medical book.		*[http://www.nickgorton.org Medical Therapy and Health Maintenance for Transgender Men: A Guide For Health Care Providers]: a free online medical book.

	[[Category:Transition]]		[[Category:Transition]]

InternetArchiveBot: Rescuing 2 sources and tagging 3 as dead.) #IABot (v2.0.9.5

2023-07-20T07:00:30Z

Rescuing 2 sources and tagging 3 as dead.) #IABot (v2.0.9.5

BinaryBot: Bot: adding archive links to references (error log).

2023-07-17T14:11:47Z

Bot: adding archive links to references (error log).

Show changes

imported>HanTheGene: stray template?

2023-03-26T17:24:27Z

stray template?

← Older revision		Revision as of 17:24, 26 March 2023
Line 229:		Line 229:

	====Sublingual and buccal====		====Sublingual and buccal====
	In 2003 the FDA approved a buccal form of testosterone (Striant). Sublingual testosterone can also be made by some compounding pharmacies. Cost for Striant is greater than other formulations (~~{{US~~$\|180–210}}/month). Testosterone is absorbed through the oral mucosa and avoids the first-pass metabolism in the liver which is cause of many of the adverse effect with oral testosterone undecanoate. The lozenges can cause gum irritation, taste changes, and headache but most side effects diminish after two weeks. The lozenge is 'mucoadhesive' and must be applied twice daily.		In 2003 the FDA approved a buccal form of testosterone (Striant). Sublingual testosterone can also be made by some compounding pharmacies. Cost for Striant is greater than other formulations ($180–210/month). Testosterone is absorbed through the oral mucosa and avoids the first-pass metabolism in the liver which is cause of many of the adverse effect with oral testosterone undecanoate. The lozenges can cause gum irritation, taste changes, and headache but most side effects diminish after two weeks. The lozenge is 'mucoadhesive' and must be applied twice daily.

	===Alternative androgens===		===Alternative androgens===

imported>KindredPando: Removed subjective framing of voice deepening as an "unfortunately" permanent effect. Everyone's transition goals are different.

2023-02-08T19:03:55Z

Removed subjective framing of voice deepening as an "unfortunately" permanent effect. Everyone's transition goals are different.

← Older revision		Revision as of 19:03, 8 February 2023
Line 40:		Line 40:
	===Voice deepening===		===Voice deepening===

	Most individuals on testosterone will experience a gradual deepening of the voice,<ref name="soc 36">World Professional Association for Transgender Health. ''The Standards of Care,'' version 7. 2012. Page 36. https://wpath.org/publications/soc</ref> caused by growth of the larynx (voice box). In most cases, this begins after 3 to 12 months, and finished after 1 to 2 years.<ref name="soc 37" /> ~~Unfortunately, the~~ changes are permanent~~. This means that~~ a trans-masculine person's voice will stay as low as it got even if they stop taking HRT. Many individuals who do not want the full effect of voice deepening will take testosterone until their voice deepens to their desired resonance and then stop.		Most individuals on testosterone will experience a gradual deepening of the voice,<ref name="soc 36">World Professional Association for Transgender Health. ''The Standards of Care,'' version 7. 2012. Page 36. https://wpath.org/publications/soc</ref> caused by growth of the larynx (voice box). In most cases, this begins after 3 to 12 months, and finished after 1 to 2 years.<ref name="soc 37" /> The changes are permanent, meaning a trans-masculine person's voice will stay as low as it got even if they stop taking HRT. Many individuals who do not want the full effect of voice deepening will take testosterone until their voice deepens to their desired resonance and then stop.

imported>TXJ: /* Effect on ability to get pregnant */

2021-03-03T23:45:45Z

Effect on ability to get pregnant

← Older revision		Revision as of 23:45, 3 March 2021
Line 99:		Line 99:

	If a transgender man is planning on having a hysterectomy/oophorectomy, future reproduction may still be preserved by:		If a transgender man is planning on having a hysterectomy/oophorectomy, future reproduction may still be preserved by:
	* Oocyte banking. Hormonal stimulation to ‘hyper-ovulate’ with transvaginal oocyte harvest for freezing. Previously using the "slow-freezing" cryopreservation method there were very poor survival rates of banked oocytes. However, the advent of vitrification, a rapid freezing process, has made oocyte cryopreservation a viable option for fertility preservation. It allows the possibility for eggs to later be fertilized and be placed in a surrogate, as opposed to a transgender man having to carry the pregnancy himself.		* Oocyte banking. Hormonal stimulation to ‘hyper-ovulate’ with transvaginal oocyte harvest for freezing. Previously using the "slow-freezing" cryopreservation method there were very poor survival rates of banked oocytes. However, the advent of vitrification, a rapid freezing process, has made oocyte cryopreservation a viable option for [[fertility preservation]]. It allows the possibility for eggs to later be fertilized and be placed in a surrogate, as opposed to a transgender man having to carry the pregnancy himself.
	* Embryo banking. Oocyte harvest as above with immediate fertilization and banking of the embryo. The sperm donor must be chosen before oophorectomy. Allows the possibility for embryos to later be placed in a surrogate, as opposed to a transgender man having to carry the pregnancy himself.		* Embryo banking. Oocyte harvest as above with immediate fertilization and banking of the embryo. The sperm donor must be chosen before oophorectomy. Allows the possibility for embryos to later be placed in a surrogate, as opposed to a transgender man having to carry the pregnancy himself.
	* Ovarian tissue banking. Ovarian tissue is frozen after oophorectomy. Even after long-term androgen therapy, ovaries usually retain usable follicles. Eventual use of frozen ovaries will require replantation into the transgender man for stimulation and harvest, but may eventually be possible in a lab as techniques for tissue culture improve. This option does not usually allow for placement into a surrogate as it may require the use of immunosuppressants on the part of the surrogate.		* Ovarian tissue banking. Ovarian tissue is frozen after oophorectomy. Even after long-term androgen therapy, ovaries usually retain usable follicles. Eventual use of frozen ovaries will require replantation into the transgender man for stimulation and harvest, but may eventually be possible in a lab as techniques for tissue culture improve. This option does not usually allow for placement into a surrogate as it may require the use of immunosuppressants on the part of the surrogate.

24.63.246.114: /* Voice deepening */

2021-01-12T02:46:43Z

Voice deepening

← Older revision		Revision as of 02:46, 12 January 2021
Line 40:		Line 40:
	===Voice deepening===		===Voice deepening===

	Most individuals on testosterone will experience a gradual deepening of the voice.<ref name="soc 36">World Professional Association for Transgender Health. ''The Standards of Care,'' version 7. 2012. Page 36. https://wpath.org/publications/soc</ref> In most cases, this begins after 3 to 12 months, and is finished after 1 to 2 years.<ref name="soc 37" /> Unfortunately, the changes are permanent. This means that a trans-masculine person's voice will stay as low as it got even if they stop taking HRT. ~~Some trans-masculine people~~ who ~~only~~ want their voice to ~~deepen a little have accomplished this by taking HRT only for as long as it took to get~~ their ~~voice how they wanted it,~~ and then stop ~~taking HRT~~.		Most individuals on testosterone will experience a gradual deepening of the voice,<ref name="soc 36">World Professional Association for Transgender Health. ''The Standards of Care,'' version 7. 2012. Page 36. https://wpath.org/publications/soc</ref> caused by growth of the larynx (voice box). In most cases, this begins after 3 to 12 months, and finished after 1 to 2 years.<ref name="soc 37" /> Unfortunately, the changes are permanent. This means that a trans-masculine person's voice will stay as low as it got even if they stop taking HRT. Many individuals who do not want the full effect of voice deepening will take testosterone until their voice deepens to their desired resonance and then stop.

← Older revision		Revision as of 07:00, 20 July 2023
Line 280:		Line 280:

	The WPATH recognizes that HRT "is a medically necessary intervention for many transsexula, transgender, and gender-nonconforming inividuals with gender dysphoria,"<ref name="soc 33-34" /> citing studies from 1998 and 2006		The WPATH recognizes that HRT "is a medically necessary intervention for many transsexula, transgender, and gender-nonconforming inividuals with gender dysphoria,"<ref name="soc 33-34" /> citing studies from 1998 and 2006
	<ref name="pfafflin">Pfäfflin, F., & Junge, A. (1998). "Sex reassignment. Thirty years of international follow-up studies after sex reassingment surgery: A comprehensive review, 1961-1991." ''International Journal of Transgenderism.'' Retrieved from ~~http~~://web.archive.org/web/20070503090247/http://www.symposion.com/ijt/pfaefflin/1000.htm</ref>		<ref name="pfafflin">Pfäfflin, F., & Junge, A. (1998). "Sex reassignment. Thirty years of international follow-up studies after sex reassingment surgery: A comprehensive review, 1961-1991." ''International Journal of Transgenderism.'' Retrieved from https://web.archive.org/web/20070503090247/http://www.symposion.com/ijt/pfaefflin/1000.htm</ref>
	<ref name="newfield">Newfield, E., Hart, S., Dibble, S., & Kohler, L. (2006). "Female-to-male transgender quality of life." ''Quality of Life Research,'' 15(9), 1447-1457. doi:10.1007/s11136-006-0002-3.</ref>		<ref name="newfield">Newfield, E., Hart, S., Dibble, S., & Kohler, L. (2006). "Female-to-male transgender quality of life." ''Quality of Life Research,'' 15(9), 1447-1457. doi:10.1007/s11136-006-0002-3.</ref>

Line 339:		Line 339:
	==References==		==References==
	{{reflist}}		{{reflist}}
	*[http://www3.interscience.wiley.com/journal/119425589/abstract Androgen Treatment of Female-to-Male] by Louis J.G. Gooren, and Erik J. Giltay (Journal of Sexual Medicine, Volume 5 Issue 4, Oct 2007)		*[http://www3.interscience.wiley.com/journal/119425589/abstract Androgen Treatment of Female-to-Male]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Louis J.G. Gooren, and Erik J. Giltay (Journal of Sexual Medicine, Volume 5 Issue 4, Oct 2007)
	*[http://www.eje-online.org/cgi/content/abstract/159/3/197 Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones] by Andreas Mueller and Louis Gooren (European Journal of Endocrinology, Vol 159, Issue 3, 197-202)		*[http://www.eje-online.org/cgi/content/abstract/159/3/197 Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones] by Andreas Mueller and Louis Gooren (European Journal of Endocrinology, Vol 159, Issue 3, 197-202)
	*[http://www3.interscience.wiley.com/journal/122667383/abstract Testosterone and Breast Cancer] by Susan A. Hall, Andre B. Araujo, Varant Kupelian, Nancy N. Maserejian, and Thomas G. Travison (Journal of Sexual Medicine, Not yet in print)		*[http://www3.interscience.wiley.com/journal/122667383/abstract Testosterone and Breast Cancer]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Susan A. Hall, Andre B. Araujo, Varant Kupelian, Nancy N. Maserejian, and Thomas G. Travison (Journal of Sexual Medicine, Not yet in print)
	*[http://www3.interscience.wiley.com/journal/122463029/abstract Absorption of Testosterone Gel 1% (Testim) from Three Different Application Sites] by Andre T. Guay, Ted M. Smith, and Laura A. Offutt (Journal of Sexual Medicine, Volume 6 Issue 9, Jun 2009)		*[http://www3.interscience.wiley.com/journal/122463029/abstract Absorption of Testosterone Gel 1% (Testim) from Three Different Application Sites]{{Dead link\|date=July 2023 \|bot=InternetArchiveBot \|fix-attempted=yes }} by Andre T. Guay, Ted M. Smith, and Laura A. Offutt (Journal of Sexual Medicine, Volume 6 Issue 9, Jun 2009)

	==External links==		==External links==
	*[http://www.ftminfo.net/ FTM Informational Network]		*[http://www.ftminfo.net/ FTM Informational Network]
	*[http://www.forge-forward.org/socialsupport/hormones2003.html FTM Hormone Information] - Very informative with different topics than this article		*[http://www.forge-forward.org/socialsupport/hormones2003.html FTM Hormone Information] - Very informative with different topics than this article
	*[http://www.dph.sf.ca.us/chn/HlthCtrs/HlthCtrDocs/TransGendprotocols.pdf Tom Waddell Clinic Transgender Protocol] - MTF and FTM clinical protocols aimed at providers		*[https://web.archive.org/web/20070315211232/http://www.dph.sf.ca.us/chn/HlthCtrs/HlthCtrDocs/TransGendprotocols.pdf Tom Waddell Clinic Transgender Protocol] - MTF and FTM clinical protocols aimed at providers
	*[http://www.nickgorton.org Medical Therapy and Health Maintenance for Transgender Men: A Guide For Health Care Providers]: a free online medical book.		*[http://www.nickgorton.org Medical Therapy and Health Maintenance for Transgender Men: A Guide For Health Care Providers]: a free online medical book.

	[[Category:Transition]]		[[Category:Transition]]